ESR1 and invasive breast carcinoma: Triple-negative breast cancer (TNBC), approximately 15% of invasive breast cancers, is the most aggressive breast cancer subtype; it lacks estrogen receptor (ER) expression, progesterone receptor (PR) expression, and HER2 gene amplification [3, 4].